Company DelMar Pharmaceuticals Inc Nasdaq
Equities
US2470782077
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 10/04/18 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 10/04/18 |
Tamara Favorito
BRD | Director/Board Member | 65 | 28/04/21 |
Laura Douglass
BRD | Director/Board Member | 59 | 25/06/20 |
Robert Toth
BRD | Director/Board Member | 60 | 19/08/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 14,000 | 0 | 0 | 99.81 % |
Stock B | 1 | 39,037,899 | 38,961,784 ( 99.81 %) | 0 | |
Stock C | 0 | 279,000 | 0 | 0 |
Company contact information
Kintara Therapeutics, Inc.
9920 Pacific Heights Boulevard Suite 150
92121, San Diego
+858 350 4364
http://www.kintara.comSector
1st Jan change | Capi. | |
---|---|---|
+9.15% | 106B | |
-1.08% | 104B | |
+6.96% | 23.25B | |
-11.55% | 22.5B | |
-7.26% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |